Weight and metabolic health intersect with epilepsy in several ways. Some antiseizure medicines can promote weight gain or weight loss, physical and social consequences of epilepsy can affect activity, and obesity itself is associated with wider cardiovascular and metabolic risk.
The association is real but complicated
A 2024 systematic review and meta-analysis found an association between epilepsy and obesity, but the studies were heterogeneous and do not show that epilepsy directly causes obesity in every person.
Age, disability, activity, sleep, mood, socioeconomic factors and medication all contribute.
Antiseizure medicines can affect weight differently
Valproate is commonly associated with weight gain. Other medicines can be relatively weight-neutral or associated with weight loss.
A 2025 systematic review and meta-analysis also found differences between individual antiseizure medicines in lipid profiles and body weight.
Metabolic syndrome is broader than body weight
Metabolic syndrome includes abnormalities such as central adiposity, blood pressure, glucose regulation and blood lipids.
People can have important metabolic risk without appearing severely overweight, and body mass index alone does not describe the whole picture.
Why this matters in long-term epilepsy care
Epilepsy treatment often continues for years. Small medication-related changes in appetite, weight or lipids can therefore become clinically important over time.
Cardiovascular health should not be ignored simply because seizure control is the main neurological priority.
Sleep and mobility can contribute
Obstructive sleep apnoea, fatigue, fear of seizures during exercise and physical disability can all affect activity and weight.
Conversely, appropriate physical activity can improve general health and quality of life for many people with epilepsy.
Weight change can alter other treatment decisions
Substantial changes in body composition can affect dosing considerations, anaesthetic planning and suitability for some procedures.
For ketogenic therapy, nutritional monitoring has a different purpose and should not be conflated with ordinary weight-loss dieting.
Management should avoid stigma
Weight is influenced by biology, medicines, environment and social factors. Clinical discussion should focus on health and treatment effects rather than blame.
When a medication is contributing to problematic weight change, alternatives can sometimes be considered without compromising seizure control.
Related reading
Sources and further reading
- Relationships between obesity and epilepsy — 2024 systematic review and meta-analysis
- Effects of antiseizure medications on lipid profile and weight — 2025 systematic review/meta-analysis
- Obesity and metabolic syndrome in people with epilepsy — review
Evidence checked: September 2026.